GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Debt-to-Revenue

RP Bio lnc (XKRX:314140) Debt-to-Revenue : 0.24 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

RP Bio lnc's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩26,005 Mil. RP Bio lnc's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩4,616 Mil. RP Bio lnc's annualized Revenue for the quarter that ended in Mar. 2024 was ₩129,954 Mil. RP Bio lnc's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.24.


RP Bio lnc Debt-to-Revenue Historical Data

The historical data trend for RP Bio lnc's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Debt-to-Revenue Chart

RP Bio lnc Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Debt-to-Revenue
0.54 0.41 0.35 0.28

RP Bio lnc Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.27 0.22 0.21 0.22 0.24

Competitive Comparison of RP Bio lnc's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, RP Bio lnc's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RP Bio lnc's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RP Bio lnc's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where RP Bio lnc's Debt-to-Revenue falls into.



RP Bio lnc Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

RP Bio lnc's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(35549.916 + 2634.805) / 138109.319
=0.28

RP Bio lnc's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(26004.604 + 4615.648) / 129953.832
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


RP Bio lnc Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


RP Bio lnc (XKRX:314140) Business Description

Traded in Other Exchanges
N/A
Address
634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084
RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc (XKRX:314140) Headlines

No Headlines